Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Stockholders' Equity

v3.24.0.1
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Cumulative Effect, Period of Adoption, Adjusted Balance
 [1]
Common Stock
Common Stock
Cumulative Effect, Period of Adoption, Adjusted Balance
 [1]
Capital in Excess of Par
Capital in Excess of Par
Cumulative Effect, Period of Adoption, Adjusted Balance
 [1]
Retained Earnings (Accumulated Deficit)
Retained Earnings (Accumulated Deficit)
Cumulative Effect, Period of Adoption, Adjustment
Retained Earnings (Accumulated Deficit)
Cumulative Effect, Period of Adoption, Adjusted Balance
 [1]
Beginning balance (in shares) at Dec. 31, 2020       39,759,000 39,759,000          
Beginning balance at Dec. 31, 2020 $ 711,002 $ 762,322 $ 1,473,324 $ 398 $ 398 $ 3,222,959 $ 3,222,959 $ (2,512,355) $ 762,322 $ (1,750,033)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net income 133,561 [2]             133,561    
Restricted stock units (in shares)       156,000            
Restricted stock units 10,951     $ 2   10,949        
Warrant exercises (in shares)       6,913,000            
Warrant exercises 134,817     $ 69   134,748        
Common stock issued for Primexx Acquisition (in shares)       9,030,000            
Common stock issued for Primexx Acquisition 420,700     $ 90   420,610        
Common stock issued for Second Lien Notes Exchange (in shares)       5,513,000            
Common stock issued for Second Lien Notes Exchange 223,147     $ 55   223,092        
Ending balance (in shares) at Dec. 31, 2021 [1]       61,371,000            
Ending balance at Dec. 31, 2021 [1] 2,396,500     $ 614   4,012,358   (1,616,472)    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net income 1,019,443 [2]             1,019,443    
Restricted stock units (in shares)       266,000            
Restricted stock units 8,738     $ 3   8,735        
Common stock issued for Primexx Acquisition (in shares)       (15,000)            
Common stock issued for Primexx Acquisition $ 1,100     $ (1)   1,101        
Ending balance (in shares) at Dec. 31, 2022 61,621,518     61,622,000 [1]            
Ending balance at Dec. 31, 2022 [1] $ 3,425,781 [3]     $ 616   4,022,194   (597,029)    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net income 401,201             401,201    
Restricted stock units (in shares)       272,000            
Restricted stock units 11,036     $ 3   11,033        
Common stock issued for Percussion Acquisition (in shares)       6,233,000            
Common stock issued for Percussion Acquisition 208,847     $ 62   208,785        
Repurchase and retirement of common stock (in shares)       (1,652,000)            
Repurchase and retirement of common stock $ (55,504)     $ (16)   (55,488)        
Ending balance (in shares) at Dec. 31, 2023 66,474,525     66,475,000            
Ending balance at Dec. 31, 2023 $ 3,991,361     $ 665   $ 4,186,524   $ (195,828)    
[1] Financial information for the prior periods has been recast to reflect retrospective application of the successful efforts method of accounting. See “Note 2 - Summary of Significant Accounting Policies” for additional information.
[2] Financial information for the prior periods has been recast to reflect retrospective application of the successful efforts method of accounting. See “Note 2 - Summary of Significant Accounting Policies” for additional information.
[3] Financial information for the prior period has been recast to reflect retrospective application of the successful efforts method of accounting. See “Note 2 - Summary of Significant Accounting Policies” for additional information.